Mitsopoulos Costas, Schierz Amanda C, Workman Paul, Al-Lazikani Bissan
Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, United Kingdom.
PLoS Comput Biol. 2015 Dec 23;11(12):e1004597. doi: 10.1371/journal.pcbi.1004597. eCollection 2015 Dec.
The interaction environment of a protein in a cellular network is important in defining the role that the protein plays in the system as a whole, and thus its potential suitability as a drug target. Despite the importance of the network environment, it is neglected during target selection for drug discovery. Here, we present the first systematic, comprehensive computational analysis of topological, community and graphical network parameters of the human interactome and identify discriminatory network patterns that strongly distinguish drug targets from the interactome as a whole. Importantly, we identify striking differences in the network behavior of targets of cancer drugs versus targets from other therapeutic areas and explore how they may relate to successful drug combinations to overcome acquired resistance to cancer drugs. We develop, computationally validate and provide the first public domain predictive algorithm for identifying druggable neighborhoods based on network parameters. We also make available full predictions for 13,345 proteins to aid target selection for drug discovery. All target predictions are available through canSAR.icr.ac.uk. Underlying data and tools are available at https://cansar.icr.ac.uk/cansar/publications/druggable_network_neighbourhoods/.
蛋白质在细胞网络中的相互作用环境对于定义该蛋白质在整个系统中所起的作用至关重要,因此也关乎其作为药物靶点的潜在适用性。尽管网络环境很重要,但在药物研发的靶点选择过程中却被忽视了。在此,我们首次对人类相互作用组的拓扑、群落和图形网络参数进行了系统、全面的计算分析,并识别出能将药物靶点与整个相互作用组显著区分开来的鉴别性网络模式。重要的是,我们发现了癌症药物靶点与其他治疗领域靶点在网络行为上的显著差异,并探讨了它们与成功的药物组合之间的关系,以克服对癌症药物的获得性耐药。我们开发了一种基于网络参数识别可药物化邻域的预测算法,并通过计算进行了验证,这也是首个公开可用的此类算法。我们还提供了针对13345种蛋白质的完整预测结果,以协助药物研发的靶点选择。所有靶点预测结果均可通过canSAR.icr.ac.uk获取。基础数据和工具可在https://cansar.icr.ac.uk/cansar/publications/druggable_network_neighbourhoods/获取。